Mario Tanguay, BPharm, PhD
Vice President, Scientific and Regulatory Affairs, Anapharm
5160 boul. Decarie, 8th Floor
Montreal, Quebec
H3X 2H9 CANADA
Tel: 514 485 7256
Fax: 514 485 7501
E-mail: mtanguay@anapharm.com
Expertise: Pharmacokinetics, bioavailability, bioequivalence, and drug interactions
Dr. Tanguay has nearly 20 years of pharmaceutical industry experience, including 5 years at Wyeth-Ayerst and Pharmacia. He has been a co-investigator in more than a thousand pharmacokinetic and Phase 1 programs, including studies of bioavailability, bioequivalence, drug interactions, first-in-human, and many others. Dr. Tanguay has been a guest lecturer on numerous occasions at Laval University, Sherbrooke University, and the University of Montréal. He is a member of many scientific associations including the American Association of Pharmaceutical Scientists (AAPS), the American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the American Society for Pharmacology and Experimental Therapeutics (ASPET).
504 Carnegie Center, Princeton, NJ 08540